New FDA Advisory Cmte. Trend: Approved Cancer Meds Get Another Look When Competitors Coming

 
• By Sarah Karlin-Smith
Competitor applicants have recently been putting previously approved drugs back in advisory committee spotlight.

More from US Advisory Committees

More from Pink Sheet